Type
. Oxidative stress and anti-oxidant status in leprosy patients. Indian journal of leprosy. 2003;75(4):307-16.
Type
. A medical legend: James L. Cunningham, M.D. The West Virginia medical journal. 2004;100(2):52-8.
Type
. Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2004;112(4-5):271-4.
Type
. What is the best way to use BCG to protect against leprosy: when, for whom, and how often?. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2004;72(1):48-9. Available from: http://ila.ilsl.br/pdfs/v72n1a07.pdf
Type
. Active surveillance of leprosy contacts in country with low prevalence rate. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2004;72(1):50-3. Available from: http://ila.ilsl.br/pdfs/v72n1a08.pdf
Type
. Shiny red-brown papules in a 21-year-old man. Histoid leprosy. Archives of dermatology. 2004;140(6):751-6.
Type
. Subcutaneous phaeohyphomycosis due to Pyrenochaeta romeroi in a patient with leprosy. Acta dermato-venereologica. 2004;84(2):154-5.
Type
. Treatment of leprosy. BMJ (Clinical research ed.) [Internet]. 2004;328(7454):1447-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC428501/pdf/bmj32801447.pdf
Type
. TUNEL and limited immunophenotypic analyses of apoptosis in paucibacillary and multibacillary leprosy lesions. FEMS immunology and medical microbiology. 2004;41(3):265-9.
Type
. An unusual cause of nonhealing wounds. Advances in skin & wound care. 2004;17(5 Pt 1):214.